Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

A Single-center, Active-controlled, Randomized, Double-blind, Proof of Concept Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application in Male Patients With Androgenetic Alopecia

This study is designed to explore the efficacy and safety of DA-4001 after topical application in male patients with androgenetic alopecia

Design : Randomized, double-blind, active-controlled study

Investigational Product : Finasteride, minoxidil

Inclusion Criteria:

• Basic and specific(BASP) classification : basic type is M2 or C2 and specific type is V1,V2 or F1,F2

Exclusion Criteria:

• Evidence of hair loss other than androgenetic alopecia
• Use of finasteride, dutasteride within previous 12 months
• Use of minoxidil within previous 6 months
• Use of androgenic or anti-androgenic agents within previous 6 months
• Use of steroid agents for local application to scalp or systemic application within previous 1 month
• History of hair transplantation, scalp reduction
• Coronary artery disease, arrhythmia, congestive heart failure, valvular haert disease, angina pectoris